DE69418183T2 - Immunotherapeutische zubereitung - Google Patents

Immunotherapeutische zubereitung

Info

Publication number
DE69418183T2
DE69418183T2 DE69418183T DE69418183T DE69418183T2 DE 69418183 T2 DE69418183 T2 DE 69418183T2 DE 69418183 T DE69418183 T DE 69418183T DE 69418183 T DE69418183 T DE 69418183T DE 69418183 T2 DE69418183 T2 DE 69418183T2
Authority
DE
Germany
Prior art keywords
present
preparation
immunotherapeutic preparation
immunotherapeutic
abort
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69418183T
Other languages
English (en)
Other versions
DE69418183D1 (de
Inventor
Stanley J Alkemade
Graeme Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetrepharm Inc
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Publication of DE69418183D1 publication Critical patent/DE69418183D1/de
Application granted granted Critical
Publication of DE69418183T2 publication Critical patent/DE69418183T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69418183T 1993-01-29 1994-01-28 Immunotherapeutische zubereitung Expired - Lifetime DE69418183T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (en) 1993-01-29 1994-01-28 Immunotherapeutic composition

Publications (2)

Publication Number Publication Date
DE69418183D1 DE69418183D1 (de) 1999-06-02
DE69418183T2 true DE69418183T2 (de) 1999-12-16

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418183T Expired - Lifetime DE69418183T2 (de) 1993-01-29 1994-01-28 Immunotherapeutische zubereitung

Country Status (11)

Country Link
US (1) US5759554A (de)
EP (1) EP0681479B1 (de)
JP (1) JPH08508976A (de)
CN (1) CN1102855C (de)
AT (1) ATE179333T1 (de)
AU (1) AU691797B2 (de)
BR (1) BR9406496A (de)
DE (1) DE69418183T2 (de)
DK (1) DK0681479T3 (de)
NZ (1) NZ261094A (de)
WO (1) WO1994016727A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US6139844A (en) * 1997-04-02 2000-10-31 Bioniche, Inc. Method for treating or eliminating a parasitic disease
EP1003525B1 (de) 1997-08-05 2002-11-20 Bioniche Life Sciences Inc. Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
DK1135164T3 (da) * 1998-12-04 2004-12-20 Bioniche Life Sciences Inc Sammensætning til behandling af inflammation
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
ATE353660T1 (de) * 1999-07-23 2007-03-15 Bioniche Life Sciences Inc Methode zur steigerung der produktionsleistung in tieren
MXPA02005842A (es) * 1999-12-13 2003-10-14 Bioniche Life Sciences Inc Oligonucleotidos sinteticos terapeuticamente utiles.
JP4215429B2 (ja) 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
KR20020091170A (ko) * 2000-03-31 2002-12-05 아이덱 파마슈티칼즈 코포레이션 Ｂ 세포 림프종의 치료를 위한 항-사이토카인 항체 또는길항제 및 항-ｃｄ２０의 조합된 사용
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
MX340143B (es) 2010-10-13 2016-06-28 Telesta Therapeutics Ip Inc Composiciones de pared de célula de ácido ribonucléico bacterial y métodos para hacerlas y usarlas.
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
CA2947358A1 (en) * 2014-02-18 2015-08-27 Advaxis, Inc. Biomarker directed multi-target immunotherapy
US20200061130A1 (en) * 2016-02-25 2020-02-27 Thomas Julius Borody Compositions and methods of treatment of chronic infectious diseases
IT202000002866A1 (it) * 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
IT202000002641A1 (it) * 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
CN113244384A (zh) * 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (de) * 1971-11-19 1975-02-07 Anvar
NL7308450A (de) * 1972-06-20 1973-12-27
US4010257A (en) * 1973-02-23 1977-03-01 Burroughs Wellcome Co. Biological extracts
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
FR2269961B1 (de) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
AU691797B2 (en) 1998-05-28
DE69418183D1 (de) 1999-06-02
DK0681479T3 (da) 1999-11-08
CN1118574A (zh) 1996-03-13
US5759554A (en) 1998-06-02
EP0681479A1 (de) 1995-11-15
AU5968094A (en) 1994-08-15
EP0681479B1 (de) 1999-04-28
ATE179333T1 (de) 1999-05-15
CN1102855C (zh) 2003-03-12
WO1994016727A1 (en) 1994-08-04
BR9406496A (pt) 1996-01-02
JPH08508976A (ja) 1996-09-24
NZ261094A (en) 1998-04-27

Similar Documents

Publication Publication Date Title
ATE179333T1 (de) Immunotherapeutische zubereitung
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
MD970199A (en) Induction of a cytotoxic T-lymphocytic answer The invention relates to the medicine, particularly to the immunology and can be used for treatment of bacterial and parasitic infections, tumors and other diseases. The summary of the invention consists in the induction of a cytotoxic T-lymphocytic answer to human and animals by means of a composition consisting of an antigene and an antigenic formulati
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
GB2149301B (en) Pyridine-soluble extract - refined detoxified endotoxin composition and use
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
PT600396E (pt) Vacinas contra protozoarios intestinais
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
CA2154689A1 (en) Improved immunotherapeutic composition
DE3373978D1 (en) Composition for the care or treatment of the human skin
SE8200748L (sv) Terapeutiskt medel
SE8303729L (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ATE202284T1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
RU95111615A (ru) Способ лечения органа или системы с низким уровнем ответной реакции на раздражители при умеренном или высоком уровне врожденной реакции организма в целом
BG51699A1 (en) Stimulating fertility agent
ES489956A0 (es) Sistema para la aplicacion de tratamientos bronceadores y terapeuticos integrales del cuerpo humano
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання

Legal Events

Date Code Title Description
8364 No opposition during term of opposition